ART Pregnancies Have Higher Exposure to Teratogenic Medications

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 22, 2025.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 22, 2025 -- Pregnancies resulting from assisted reproductive technology (ART) have a higher prevalence of exposure to teratogenic medicines, according to a study published online Dec. 9 in the Australian and New Zealand Journal of Obstetrics and Gynaecology.

Anna Kemp-Casey, Ph.D., from University of South Australia in Adelaide, and colleagues examined datasets for births in Western Australia (with a conception date on or after July 1, 2012, and date of birth on or before Dec. 31, 2014) to assess whether exposure to teratogenic medicines during pregnancy varies by conception method (ART [2,041 pregnancies] and three non-ART groups: ovulation induction [OI; 590 pregnancies], subfertile untreated [2,063 pregnancies], and fertile naturally conceiving [52,987 pregnancies]).

The researchers found that the overall prevalence of exposure to Category D/X medicines was 0.8 percent in the first trimester and 0.7 percent in the second and third trimesters. For all conception groups and trimesters, Category X medicine exposure was <0.5 percent. Compared with subfertile and fertile pregnancies, the first trimesters of ART and OI pregnancies were more often exposed to Category D medicines (ART, 4.9 percent; OI, 2.0 percent; subfertile, 1.3 percent; fertile, 0.6 percent) as were later trimesters (ART, 3.4 percent; OI, 1.4 percent; subfertile, 0.9 percent; fertile, 0.6 percent).

"The overall prevalence of exposure to teratogenic medicines is low; however, exposure was greatest in pregnancies arising from ART and may be a modest contributing factor to the higher rate of birth defects observed among ART babies," the authors write.

Several authors disclosed ties to the fertility treatment industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-23 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords